Paper26972772
NKT cell subsets as key participants in liver physiology and pathology.
Bandyopadhyay K and 2 others. Cell Mol Immunol, 2016. Cited by 155 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. NKT cell subsets as key participants in liver physiology and pathology. Papers, record 26972772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26972772
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver | Major topic |
| Lymphocyte Subsets | Major topic |
| Natural Killer T-Cells | Major topic |
| Animals | |
| Antigens | |
| Humans | |
| Lymphocyte Activation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AA020864 | NIAAA NIH HHS | United States | R01AA020864 | PubMed and NIH | NIH RePORTER |
| R01CA100660 | NIH | NIH RePORTER |
References124
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22,251,704 | Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22251704 | PubMed |
| 2 | 20,034,047 | Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. | Hepatology | 2010 | https://conductscience.org/library/papers/20034047 | PubMed |
| 3 | 16,175,608 | Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. | Hepatology | 2005 | https://conductscience.org/library/papers/16175608 | PubMed |
| 4 | 19,342,695 | Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors. | J Immunol | 2009 | https://conductscience.org/library/papers/19342695 | PubMed |
| 5 | 20,139,988 | Raising the NKT cell family. | Nat Immunol | 2010 | https://conductscience.org/library/papers/20139988 | PubMed |
| 6 | 26,136,748 | Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer. | Front Immunol | 2015 | https://conductscience.org/library/papers/26136748 | PubMed |
| 7 | 19,592,275 | Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors. | Immunity | 2009 | https://conductscience.org/library/papers/19592275 | PubMed |
| 8 | 22,820,603 | Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor. | Nat Immunol | 2012 | https://conductscience.org/library/papers/22820603 | PubMed |
| 9 | 24,166,975 | Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. | J Immunol | 2013 | https://conductscience.org/library/papers/24166975 | PubMed |
| 10 | 19,556,980 | A cell biological view of Toll-like receptor function: regulation through compartmentalization. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19556980 | PubMed |
| 11 | 25,661,730 | Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration. | Cell Mol Immunol | 2016 | https://conductscience.org/library/papers/25661730 | PubMed |
| 12 | 20,950,612 | Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. | Gastroenterology | 2011 | https://conductscience.org/library/papers/20950612 | PubMed |
| 13 | 21,740,985 | Role of NKT cells in autoimmune liver disease. | Autoimmun Rev | 2011 | https://conductscience.org/library/papers/21740985 | PubMed |
| 14 | 12,368,312 | Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. | J Virol | 2002 | https://conductscience.org/library/papers/12368312 | PubMed |
| 15 | 19,201,769 | Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. | Gut | 2009 | https://conductscience.org/library/papers/19201769 | PubMed |
| 16 | 24,260,285 | Cross-activating invariant NKT cells and kupffer cells suppress cholestatic liver injury in a mouse model of biliary obstruction. | PLoS One | 2013 | https://conductscience.org/library/papers/24260285 | PubMed |
| 17 | 18,471,544 | Cellular and molecular mechanisms of liver injury. | Gastroenterology | 2008 | https://conductscience.org/library/papers/18471544 | PubMed |
| 18 | 23,296,703 | Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease. | J Immunol | 2013 | https://conductscience.org/library/papers/23296703 | PubMed |
| 19 | 18,981,087 | Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy. | J Immunol | 2008 | https://conductscience.org/library/papers/18981087 | PubMed |
| 20 | 20,228,796 | An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. | Nat Immunol | 2010 | https://conductscience.org/library/papers/20228796 | PubMed |
Cited by118
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,855,466 | Microbial cues and T cell immunity: deciphering their interactions in chronic liver disease. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42855466 | PubMed |
| 42,708,866 | The Defect of iNKT Cells Mediates Mitochondrial Dysfunction Through IL-6/STAT3 Signaling to Induce Atrial Inflammation and Fibrosis to Aggravate Postoperative Atrial Fibrillation. | Physiol Res | 2026 | https://conductscience.org/library/papers/42708866 | PubMed |
| 42,601,419 | Detection of Natural Killer and Natural Killer T Cells Responses among Patients with Chronic Hepatitis C Infections in Sana'a City-Yemen. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42601419 | PubMed |
| 42,432,768 | The diversity of STING in regulating immune cell function and its role in liver diseases: from bench to bedside. | Cell Biosci | 2026 | https://conductscience.org/library/papers/42432768 | PubMed |
| 42,358,991 | Integrated single-cell and spatial transcriptomics reveal immune landscape and NKT-Th1 signatures in colorectal cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42358991 | PubMed |
| 42,353,388 | The Pro-Inflammatory Action of Different Pathogen-Associated Molecular Patterns in Porcine Hepatic and Intestinal Cell Cultures. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42353388 | PubMed |
| 42,148,091 | The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction. | Front Immunol | 2026 | https://conductscience.org/library/papers/42148091 | PubMed |
| 42,064,073 | Immune cells in liver injury: from pathogenic mechanisms to immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42064073 | PubMed |
| 41,903,685 | Conserved Ductular Reaction Mechanisms in Biliary Atresia and Primary Sclerosing Cholangitis Derived From Single-Cell and Spatial Transcriptomics. | Cell Mol Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41903685 | PubMed |
| 41,821,922 | Hepatic Viral Reservoirs in Concurrent HIV and HBV: From Mechanistic Insight to Integrated Cure Strategies. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/41821922 | PubMed |
| 41,543,487 | Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytes. | Hepatol Commun | 2026 | https://conductscience.org/library/papers/41543487 | PubMed |
| 41,492,190 | Clinical applications of immunogenomics in hepatocellular carcinoma. | Clin Mol Hepatol | 2026 | https://conductscience.org/library/papers/41492190 | PubMed |
| 41,160,198 | Functions and clinical implications of the liver microenvironment in hepatic uveal melanoma metastases. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/41160198 | PubMed |
| 41,136,986 | Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learning. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41136986 | PubMed |
| 40,747,238 | Liver immunology: Biological role and clinical significance. | World J Hepatol | 2025 | https://conductscience.org/library/papers/40747238 | PubMed |
| 40,600,791 | Kupffer Cells Regulate iNKT Cells Through Il-12 to Mitigate the Extent of APAP-Induced Damage in the Liver. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40600791 | PubMed |
| 40,520,296 | Association between atherogenic index of plasma and physical dysfunction: a cross-sectional study of middle-aged and older adults in China. | Front Public Health | 2025 | https://conductscience.org/library/papers/40520296 | PubMed |
| 40,512,622 | De-coupling immune parameters and toxicity associated with IL-12 agonism. | Cell Rep | 2025 | https://conductscience.org/library/papers/40512622 | PubMed |
| 40,461,700 | Liver macrophages: development, dynamics, and functions. | Cell Mol Immunol | 2025 | https://conductscience.org/library/papers/40461700 | PubMed |
| 40,330,481 | Coinfection with HIV-1 skews iNKT cells toward TCR anergy and limited expansion potential in people with hepatitis C. | Front Immunol | 2025 | https://conductscience.org/library/papers/40330481 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26972772
GET https://conductscience.org/api/papers/v1/26972772/references?page=2